Skip to main content
. 2016 Sep 22;7(45):73045–73054. doi: 10.18632/oncotarget.12196

Showing better recurrence free survival in patients with no loss of heterozygosity or deletion of chromosome 9p.

Showing better recurrence free survival in patients with no loss of heterozygosity or deletion of chromosome 9p